Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer
Reports and Proceedings
Reports and Proceedings
Latest News Releases
Updates every hour. Last Updated: 25-Oct-2026 03:16 ET (25-Oct-2026 07:16 GMT/UTC)
Reports and Proceedings
Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC
Reports and Proceedings
Subcutaneous tarlatamab shows favorable safety profile and antitumor activity in extensive-stage small cell lung cancer
Reports and Proceedings
New ‘smart’ nanoparticles help the immune system better attack tumours
Peer-Reviewed Publication
FDA clears CU Anschutz clinical trial using engineered immune cells to fight colorectal cancer
Business Announcement
Obesity may remove a natural defense against breast cancer
Peer-Reviewed Publication
Chemotherapy alters ‘Darwinian battleground’ in our bodies
Peer-Reviewed Publication
Multimodal AI roadmaps the future of personalized cancer immunotherapy
Peer-Reviewed Publication
Giant-nucleus cells are key markers for early-stage cancer, study shows
Peer-Reviewed Publication
Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance
Peer-Reviewed Publication